옵션 체인은 다양한 행사가격과 만기일에 대한 Veren의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Veren에 대한 시장 심리를 평가합니다..

Veren (NYSE:VRN) 주식, 옵션 체인

Veren

Veren Inc is an oil producer company. It is engaged in acquiring, developing, and holding interests in petroleum assets operations across western Canada.

D-Wave Quantum Inc.

Equities

Mid Cap

News

Movers

Trading Ideas

HSAI

IONQ

ORLA

PTGX

QBTS

RGTI

SMTC

이 중형주들은 지난주에 가장 좋은 성과를 냈습니다. 당신의 포트폴리오에 있나요? 1. D-웨이브 퀀텀(NYSE:QBTS)의 주식은 회사가 4분기 수주가 1억 8,300만 달러로 전년 대비 502% 증가했다고 보고한 후 95.95% 상승했다.

D-웨이브 퀀텀과 아이온큐 등 지난주 급등한 중형주 8종목 (3월 10일-3월 14일)

Veren Inc

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

VERANO HLDGS CORP by Verano Holdings Corp.

Verano Holdings Corp

Varonis Systems Inc

Verint Systems Inc

Jefferies analyst Julien Dumoulin-Smith downgrades TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) from Hold to Underperform and lowers the price target from $2.3 to $0.5.

Downgrades

Price Target

Analyst Ratings

TPIC

Jefferies Downgrades TPI Composites to Underperform, Lowers Price Target to $0.5

TIGR: 8% &#x7C; <a href="https://www.benzinga.com//node/44371198">UP Fintech Holding Q4 Adj $0.17 Beats $0.11 Estimate, Sales $124.10M Beat $97.00M Estimate</a>
&nbsp;
RL: 3% &#x7C; <a href="https://www.benzinga.com//node/44373413">Ralph Lauren shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $280 to $286.</a>
&nbsp;
BBAI: -9% &#x7C; <a href="https://www.benzinga.com//node/44373404">BigBear.ai shares are trading lower after the company said it identified the need to restate certain prior financial statements.</a>

BBAI

TIGR

Market-Moving News for March 18th

General

DPRO

Draganfly Completes Demonstration For Simulated Delivery Of Medical Supplies With Massachusetts Department of Transportation

HC Wainwright &amp; Co. analyst Robert Burns maintains OnKure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKUR#NASDAQ">OKUR</a>) with a Buy and lowers the price target from $40 to $34.

OKUR

HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $34

Tech

VERI

Veritone's AI solutions And Software Added To Carahsoft Canada's Supply Arrangement For SaaS Government of Canada Method Of Supply

Evercore ISI Group analyst Amit Daryanani maintains Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Outperform and raises the price target from $260 to $275.

AAPL

Evercore ISI Group Maintains Outperform on Apple, Raises Price Target to $275

WIIM

Tencent Music shares are trading higher after the company reported better-than-expected Q4 sales.

Ralph Lauren shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $280 to $286.

BigBear.ai shares are trading lower after the company said it identified the need to restate certain prior financial statements.

NWTG

Newton Golf Launches New Corporate and Investor Relations Website

RDHL

RedHill Biopharma Plans To Submit FDA Approved Talicia Used To Treat H. Pylori Infection For UK Marketing Approval

Biotech

Health Care

PRME

Prime Medicine Unveiled A Preclinical Program For The Treatment Of Alpha-1 Antitrypsin Deficiency, The Next Program Within Its Liver Franchise. Prime Medicine Expects To File An Investigational New Drug And/Or Clinical Trial Application In Mid-2026

TLRY

Tilray Brands Company Manitoba Harvest Expands Into Functional Snacking With New Superseed Snack Clusters

BABA

RYDE

Ryde Assimilates Alipay To Boost Payment Experience For International Visitors In Singapore

Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(1.52) by 42.76 percent. This is a 24.35 percent increase over losses of $(1.15) per share from the same period last year.

Earnings

ACXP

Acurx Pharmaceuticals FY 2024 GAAP EPS $(0.87) Beats $(1.52) Estimate

Chardan Capital analyst Daniil Gataulin maintains CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy and maintains $14 price target.

CRVO

Chardan Capital Maintains Buy on CervoMed, Maintains $14 Price Target

KRRO

Korro Bio 2020 EPS $(9.37)

Management

NeoGenomics Promotes Warren Stone To President & COO, Effective April 1, 2025

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCEL#NASDAQ">RCEL</a>) with a Buy and maintains $22 price target.

RCEL

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $22 Price Target

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Spectral AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDAI#NASDAQ">MDAI</a>) with a Buy and maintains $3.5 price target.

Reiteration

MDAI

HC Wainwright & Co. Reiterates Buy on Spectral AI, Maintains $3.5 Price Target

Commodities

Press Releases

Veren Announces Strategic Infrastructure Transaction

Veren Announces Q3 2024 Conference Call

Dividends

Veren Confirms Quarterly Dividend

Veren Announces Q3 2024 Results & Updated Outlook

Veren Announces 2024 Reserves & Board Appointments

Veren Announces Q4 & Full Year 2024 Results Conference Call

Veren Announces Q4 & Full Year 2024 Results

Veren Announces Filing of Annual Information Form and Form 40-F

WHITECAP RESOURCES AND VEREN TO COMBINE IN A $15 BILLION TRANSACTION TO CREATE A LEADING CANADIAN LIGHT OIL AND CONDENSATE PRODUCER

Comments

Veren

Veren (VRN) 옵션

Veren (NYSE:VRN) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌